A prospective, randomized, phase ii study to assess the schemas of retreatment with lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (reluth)

HIGHLIGHTS

• who: Emmanuel Deshayes from the Nuclear Medicine Department, Montpellier Cancer Institute (ICM), University of Montpellier, des Apothicaires, Montpellier, France have published the Article: A prospective, randomized, phase II study to assess the schemas of retreatment with Lutatherau00ae in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH), in the Journal: (JOURNAL)

SUMMARY

Study design and objectives Treatments Ancillary study The database will be hosted by the Institut du Cancer Montpellier, Montpellier, France. Participant data will be available upon reasonable request and with the completion of a contract between the sponsor . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.